Midwest Children's Health Research Institute | South Office

Research site

(Unclaimed)

Location

4020 Hohensee Drive, Lincoln, Nebraska, United States of America

Site insights

Top conditions

Top treatments

Donepezil Hydrochloride

rLP2086

Lubiprostone

Dextromethorphan

Eszopiclone

HCl

Parent organization

This site is a part of Midwest Children's Health Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 37 total trials

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age (MMRVNS 20-002)

The purpose of this study is to evaluate how consistently 3 different manufacturing lots of the GSK's investigational measles, mumps, rubella, and va...

Begins enrollment this month

Rubella

Varicella (Chickenpox)

Biological: MMRVNS vaccine

Biological: DTaP-IPV vaccine

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Active, not recruiting

Pneumococcal Disease

Biological: 15-valent pneumococcal conjugate vaccine (PCV15)

Biological: PG4

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling

Pneumococcal Disease

Biological: PG4

Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcu...

Enrolling

Healthy

Biological: Infanrix hexa

Biological: Prevnar 20

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneu...

Active, not recruiting

Pneumococcal Immunization

Biological: Varivax

Biological: M-M-R II vaccine

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling

Pneumococcal Disease

Biological: PG4

Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)